Compound reduces inflammation in COVID-19-infected mice without compromising immune response to virus

by

Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune response to SARS-CoV-2, the virus that causes the disease.

Leave A Comment

Your email address will not be published. Required fields are marked *